曲美他嗪治疗老年冠心病合并心力衰竭患者的疗效评价
被引量:17
摘要
目前冠状动脉粥样硬化性心脏病合并慢性心力衰竭是心血管疾病中发病率最高的疾病之一。近年来,随着血管紧张素Ⅱ受体拮抗剂(ARB)、
出处
《实用临床医药杂志》
CAS
2013年第24期104-105,共2页
Journal of Clinical Medicine in Practice
参考文献6
-
1贾合磊,孙盘丽.曲美他嗪治疗慢性充血性心力衰竭临床观察[J].中华实用诊断与治疗杂志,2011,25(9):903-904. 被引量:11
-
2Gao D, Ning N, Niu X, et al. Trimetazidine: a meta - analy- sis of randomised controlled trials in heart failure [ J ]. Heart, 2011, 97(4): 278.
-
3Belardinelli R, Solenghi M, Volpe L, et al. Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect[J]. Eur Heart J, 2007, 28(9): 1102.
-
4Gunes Y, Guntekin U, Tuncer M, et al. Improved left and right ventricular functions with trimetazidine in patients with heart failure: a tissue Doppler study[J]. Heart Vessels, 2009, 24(4): 277.
-
5Cera M, Salerno A, Fragasso G, et al. Beneficial electrophysi- ological effects of trimetazidine in patients with postischemic chronic heart failure[J]. J Cardiovasc Pharmacol Ther, 2010, 15(1): 24.
-
6曾勇,朱文玲,方全,张抒扬,王廉一,陈明哲,方理刚,郭立琳.曲美他嗪改善老年缺血性心肌病患者心脏功能的研究[J].中华老年医学杂志,2008,27(1):22-25. 被引量:18
二级参考文献20
-
1曲美他嗪Ⅳ期临床试验协作组.曲美他嗪治疗冠心病合并左心功能不全患者的疗效研究[J].中华心血管病杂志,2005,33(9):793-795. 被引量:123
-
2Wiemer M, Langer C, Kottmann T, et al. Outcome in the elderly undergoing percutaneous coronary intervention with sirolimus-eluting stents: results from the prospective multicenter German Cypher Stent Registry. Am Heart J, 2007,154:682-687.
-
3Detry JM, Sellier P, Pennaforte S, et al. Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Br J Pharmacol, 1994,37:279-288.
-
4Rosano GM, Vitale C, Sposato B, et al. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo- controlled study. Cardiovasc Diabetol, 2003,2 : 16.
-
5Fragasso G, Piatti Md PM, Monti L, et al. Short and long term beneficial effects of trimetazidine in patients with diabetes and ischemic eardiomyopathy. Am Heart J, 2003,146:18.
-
6Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography : American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of two-dimensional eEchocardiograms. J Am Soc Echocardiogr, 1989,2: 358-367.
-
7Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme a thiolase. Circ Res, 2000,86..580-588.
-
8Renaud JF. Internal pH, Na^+ and Ca^2+ regulation by trimetazidine during cardiac cell acidosis. Cardiovase Drugs Ther, 1988,1:677-686.
-
9Brottier L, Baart JL, Combe C, et al. Therapeutic value of a cardioprotective agent in patients with severe ischemic cardiomyopathy. Eur Heart J, 1990,11 : 207- 212.
-
10Belardinelli R, Purcaro A. Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischemic cardiomyopathy, gur Heart J, 2001,22:2164-2170.
共引文献27
-
1巨涛.曲美他嗪治疗慢性充血性心力衰竭的疗效分析[J].今日健康,2016,15(12):40-40.
-
2沈一同.心肌能量调节剂——曲美他嗪在心力衰竭中的应用[J].现代诊断与治疗,2011,22(1):32-34. 被引量:14
-
3欧荣华,文书银,邓小健.曲美他嗪对高血压心脏病患者治疗作用观察[J].中国医药指南,2011,9(13):201-203. 被引量:8
-
4张甲寅.老年缺血性心肌病的临床观察与治疗[J].现代预防医学,2011,38(11):2209-2210.
-
5尹海平.曲美他嗪治疗老年缺血性心肌病46例疗效[J].中国老年学杂志,2011,31(16):3159-3160. 被引量:10
-
6欧荣华,文书银,邓晓剑.曲美他嗪对2型糖尿病合并心力衰竭患者的治疗作用观察[J].中国医药指南,2011,9(25):183-184. 被引量:1
-
7王东伟,刘敏,孙广信,王全河,纪焕文,张晓君.曲美他嗪联合美托洛尔缓释片治疗缺血性心力衰竭疗效观察[J].中国实用医刊,2012,39(6):6-7. 被引量:4
-
8傅强.缺血性心肌病40例临床分析[J].按摩与康复医学,2012,3(12):250-250.
-
9陈浩,庄兰平,次仁罗布,刘金凤,边旺.培哚普利联合比索洛尔治疗高原地区慢性充血性心力衰竭疗效观察[J].中华实用诊断与治疗杂志,2012,26(5):489-491. 被引量:4
-
10安俊凤.曲美他嗪在急性心肌梗死患者长期应用的疗效观察[J].中国医药指南,2012,10(25):177-178. 被引量:2
同被引文献85
-
1赵明中.冠心病患者介入术后的社区随访[J].中华全科医师杂志,2006,5(9):527-528. 被引量:5
-
2Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation, 2011,11 ( 22 ) : 195-196.
-
3Klein L, O' Connor CM, Leimberger JD, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: result from (OFFIME-CHF) study. Circulation, 2012, 111: 2454-2460.
-
4闫建萍.阿托伐他汀联合曲美他嗪治疗冠心病的疗效观察[J].实用心脑肺血管病杂志,2013,21 (1): 103.
-
5Saunders JT, Nambi V, de Lemos JA, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart dis- ease, heart failure, and mortality in the atherosclerosis risk in communities study [J]. Circulation, 2011, 123 (13).- 1367- 1376.
-
6Butler J. An overview of chronic heart failure management[J]. Nurs Times,2012,108(14-15) : 16-20.
-
7Dedkova EN, Seidlmayer LK, Blatter LA. Mitochondria media- ted cardioprotection by trimetazidine in rabbit heart failure[J]. J Mol Cell Cardiol, 2018, 59=41-54.
-
8Zhang L, Lu Y,Jiang H, et al. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis [J]. Am Coil Cardiol, 2012, 59(10) :913 922.
-
9田志,梅霞,王骄,谢英.美托洛尔与曲美他嗪对冠心病舒张功能不全患者的干预研究Δ[J].中国药房,2010,21(36):3379-3381. 被引量:11
-
10秦艳玲,李红英,王英杰.对老年心力衰竭患者实施循证式现代优质护理的体会[J].中国医学创新,2010,7(25):143-144. 被引量:17
引证文献17
-
1解永芳.血管紧张素转化酶抑制剂与血管紧张素受体阻滞剂治疗充血性心力衰竭效果对比[J].心血管病防治知识(学术版),2014,4(11):95-96. 被引量:5
-
2刘美丽.观察曲美他嗪治疗冠心病心力衰竭的临床疗效[J].家庭心理医生,2015,11(3):321-321.
-
3李小霞,单艳华,王喜梅.复方丹参滴丸与曲美他嗪联合应用治疗不稳定型心绞痛的临床疗效观察[J].中国实用医药,2015,10(12):160-161. 被引量:5
-
4王冬梅,乔云峰.曲美他嗪对冠心病左心功能不全疗效观察分析[J].中国卫生标准管理,2015,6(23):121-122. 被引量:1
-
5李平,李佑美.曲美他嗪联合美托洛尔治疗冠心病心力衰竭对血浆BNP影响及疗效观察[J].海南医学院学报,2016,22(2):126-128. 被引量:241
-
6何向阳.曲美他嗪联合麝香保心丸治疗不稳定型心绞痛疗效探讨[J].基层医学论坛,2016,20(8):1051-1052. 被引量:3
-
7高桂丽.曲美他嗪对冠状动脉粥样硬化性心脏病合并慢性心力衰竭患者心功能指标及血清NT—proBNP水平的影响[J].国际医药卫生导报,2017,23(5):701-704. 被引量:8
-
8张远荣,吴兵.试析丹参多酚酸盐治疗老年冠心病合并心力衰竭的临床效果[J].北方药学,2017,14(5):86-87. 被引量:4
-
9韦耀.美托洛尔联合曲美他嗪治疗冠心病心力衰竭的临床疗效分析[J].实用临床医药杂志,2017,21(15):183-184. 被引量:82
-
10改哲.曲美他嗪联合三磷酸腺苷配合康复运动对冠心病患者自主神经功能的影响[J].中国疗养医学,2017,26(10):1061-1063. 被引量:5
二级引证文献383
-
1郭常明,和传波.缬沙坦治疗慢性心力衰竭时不同药物剂量的临床效果观察[J].智慧健康,2021,7(7):120-122. 被引量:1
-
2陈小倩.循证护理对老年冠心病并发心力衰竭患者的影响[J].智慧健康,2020,0(6):166-167. 被引量:4
-
3赖宇星.冠心病心力衰竭患者药物治疗的临床疗效研究[J].血管与腔内血管外科杂志,2019,5(6):502-504. 被引量:3
-
4闫丙龙,马思远,刘羽彤,赵卓.美托洛尔联合曲美他嗪对冠心病心力衰竭患者炎性因子、T细胞亚群及心功能的影响研究[J].实用心脑肺血管病杂志,2021,29(S01):38-40. 被引量:1
-
5袁雯,周霄云,张雅丽.中医护理技术对冠心病患者心理状况、生活质量及睡眠质量的影响[J].中华全科医学,2020,0(1):150-153. 被引量:39
-
6贾丽.隔物灸法治疗阳虚体质冠心病的临床价值研究[J].世界最新医学信息文摘,2019,0(79):183-183. 被引量:4
-
7邵健.保元汤加味联合美托洛尔治疗冠心病心力衰竭的疗效观察[J].内蒙古中医药,2021,40(7):56-57.
-
8卢翠莲.麝香保心丸联合瑞舒伐他汀治疗对老年冠心病患者血脂、血管内皮功能及外周血microRNA-126和microRNA-137表达的影响[J].中国动脉硬化杂志,2020,0(2):158-162. 被引量:38
-
9伏开全,尹德录,李群星,邵泽波,邵扬歌.盐酸曲美他嗪联合托伐普坦对CHD伴难治性HF患者sCD146、NT-proBNP水平及心功能的影响[J].湖南师范大学学报(医学版),2020(6):58-61. 被引量:2
-
10刘亚兵.美托洛尔联合曲美他嗪在冠心病心力衰竭治疗中对心功能的改善作用[J].黑龙江中医药,2021,50(5):128-128. 被引量:1
-
1元春敏.血管紧张素Ⅱ受体拮抗剂(ARB)氯沙坦在高血压治疗中的作用分析[J].世界最新医学信息文摘,2013,13(14):222-222.
-
2杨新春,常宇峰.高血压病药物治疗六原则[J].药物与人,2004(1):38-39. 被引量:1
-
3刘国树.血管紧张素Ⅱ受体拮抗剂临床研究[J].中国循环杂志,2002,17(5):331-333. 被引量:7
-
4李宏才.缬沙坦治疗慢性心力衰竭临床分析[J].医药论坛杂志,2010,31(13):55-56. 被引量:2
-
5杨钢,严铭玉,王鸣和.血管紧张素Ⅱ受体拮抗剂治疗充血性心力衰竭的近况[J].国外医药(合成药.生化药.制剂分册),2000,21(6):341-343. 被引量:3
-
6邓洁,王端萍,等.血管紧张素Ⅱ受体拮抗剂在心血管疾病中的运用[J].中华临床医药杂志(北京),2001,2(12):56-57.
-
7孔繁和,高伟勤,张洪亮.替米沙坦治疗轻中度高血压的疗效观察[J].黑龙江医药科学,2009,32(5):94-94.
-
8郭方明,陈宝焕.血管紧张素Ⅱ受体拮抗剂新进展[J].中国综合临床,2000,16(11):805-806.
-
9薛春燕,苏慧.血管紧张素Ⅱ受体拮抗剂治疗高血压病合并充血性心力衰竭的对比研究[J].医学信息(医学与计算机应用),2000,13(8):461-462.
-
10段小燕.血管紧张素受体拮抗剂的研究进展[J].医学文选,2000,19(2):223-225.